| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/04/2002 | WO2001053353A3 Recombinant antibodies to human interkleukin-1 beta |
| 04/04/2002 | WO2001053352A3 Sperm specific proteins |
| 04/04/2002 | WO2001051616A3 Techniques for growth and differentiation of human pluripotent stem cells |
| 04/04/2002 | WO2001050848A3 Clonal propagation of primate offspring by embryo splitting |
| 04/04/2002 | WO2001049715A3 Methods and compositions for inhibiting neoplastic cell growth |
| 04/04/2002 | WO2001048231A3 Method of achieving persistent transgene expression |
| 04/04/2002 | WO2001044290A3 Plant with enhanced pathogen resistance |
| 04/04/2002 | WO2001044277A3 Herbicide target genes and methods |
| 04/04/2002 | WO2001034802A3 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 04/04/2002 | WO2001012777A9 Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species |
| 04/04/2002 | WO2000072021A3 Cancer associated antigens and uses therefor |
| 04/04/2002 | WO2000070099A3 Differential gene expression in specific regions of the brain in neurodegenerative diseases |
| 04/04/2002 | WO2000061808A9 Methods for detecting nucleic acids indicative of cancer |
| 04/04/2002 | WO2000057909A9 Attenuated dengue-2 virus vaccine |
| 04/04/2002 | WO2000047740A9 Tnf-related proteins |
| 04/04/2002 | US20020040489 Expressed sequences of arabidopsis thaliana |
| 04/04/2002 | US20020040488 Synthases |
| 04/04/2002 | US20020040485 Transgenic systems for the manufacture of poly(2-hydroxy-butyrate-co-3-hydroxyhexanoate) |
| 04/04/2002 | US20020040484 Administering to cell a compound capable of modulating protein complex having a first protein which is delta -catenin interacting with a second protein which is FAK2 |
| 04/04/2002 | US20020040132 Using one or more agonists and/or antagonists of the G protein coupled receptor GPR56 as test compounds in one or more appetite control test procedures, and selecting an active compound for use as an appetite control agent |
| 04/04/2002 | US20020040131 Novel human metalloprotease and polynucleotides encoding the same |
| 04/04/2002 | US20020040130 Polymorphic kinase anchor proteins and nucleic acids encoding the same |
| 04/04/2002 | US20020040129 Nucleotide sequences encoding the glk-gene |
| 04/04/2002 | US20020040127 Nucleotide sequences which code tumor protein for use in diagnosis, prevention and treament of tumors |
| 04/04/2002 | US20020040009 Novel ratA |
| 04/04/2002 | US20020040000 Human kcnq5 potassium channel, methods and compositions thereof |
| 04/04/2002 | US20020039991 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/04/2002 | US20020039789 Method for production of neuroblasts |
| 04/04/2002 | US20020039786 Generating progenitor cells; provide cells for organ grafting, propagate cells, recover cells |
| 04/04/2002 | US20020039780 Salicyclic acid inducible genes and promoters |
| 04/04/2002 | US20020039778 Isolated and purified DNA molecule and protein for the degradation of triazine compounds |
| 04/04/2002 | US20020039777 Cdna encoding plant-derived epoxide hydrolase, gene encoding same and transformant |
| 04/04/2002 | US20020039775 Nucleotide sequences coding enzymatic polypeptide for use in the diagnosis and treatment of cancers |
| 04/04/2002 | US20020039773 47885, a novel human ubiquitin-activating enzyme and uses therefor |
| 04/04/2002 | US20020039772 Method of increasing recovery of heterologous active enzymes produced in plants |
| 04/04/2002 | US20020039765 Viral polypeptide for use as tool in genetic engineering and gene therapy |
| 04/04/2002 | US20020039763 Interferon-like protein Zcyto21 |
| 04/04/2002 | US20020039761 Ketogulonigenium shuttle vectors |
| 04/04/2002 | US20020039759 Polypeptide for use in the prevention of bacterial infection |
| 04/04/2002 | US20020039758 Fermentative production of valuable compounds on an industrial scale using chemically defined media |
| 04/04/2002 | US20020039746 Methods for identifying peripheral benzodiazepine receptor binding agents |
| 04/04/2002 | US20020039744 Recovering target nucleotide sequences from library; obtain sample and primer, mix, incubate, amplify nucleotide sequences, transform cells, recover nucleotide sequences from cells |
| 04/04/2002 | US20020039742 Staining solid carrier with Dna and detector zones; incubation, electrostatic bonding |
| 04/04/2002 | US20020039741 Antitumor agent |
| 04/04/2002 | US20020039740 Accurately determining binding association on microarrays of genomic samples; obtain samples, measure binding associations, compare to control, determine accracy of measurements |
| 04/04/2002 | US20020039737 Determining velocity of elongated biopolymer; classify segment of biopolymer, transfer biopolymer through detection zones, monitor signal amplitude, measure signal amplitude profiles, analyze signal to determine biopolymer velocity |
| 04/04/2002 | US20020039736 Reacting aliphatic aminonitrile with water in presence of solid alumina catalyst to form lactam |
| 04/04/2002 | US20020039734 Detecting preferential lymphocytes in sample; obtain lymphocyte, compare concentration of markers with wild type, adjustment in concentration of markers indicates presence of helper lymphocytes |
| 04/04/2002 | US20020039732 Amplification; hybridization |
| 04/04/2002 | US20020039729 Methods & compositions for identifying a protease |
| 04/04/2002 | US20020039724 Neural progenitor cell populations |
| 04/04/2002 | US20020039589 Veterinary medicine; against Pasteurella caused disease |
| 04/04/2002 | US20020039585 Mutants of streptococcal toxin c and methods of use |
| 04/04/2002 | US20020039583 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 04/04/2002 | US20020039581 Antibodies against CTLA4 and uses therefor |
| 04/04/2002 | US20020039580 Method for the high level expression of active lymphotoxin-beta receptor immunoglobulin chimeric proteins and their purification |
| 04/04/2002 | US20020039575 Supplying polypepties |
| 04/04/2002 | US20020039574 Delivery of therapeutic gene products by intestinal cell expression |
| 04/04/2002 | DE10108838A1 Neue für das hisC2-Gen kodierende Nukleotidsequenzen New coding for the hisC2 gene nucleotide sequences |
| 04/04/2002 | DE10047286A1 Isomalt produzierende transgene Pflanze Isomalt producing transgenic plant |
| 04/04/2002 | DE10047272A1 Verfahren zur Fusion von dendritischen Zellen mit erkrankten Gewebezellen, insbesondere Tumorzellen und Medien für solche Verfahren Process for the fusion of dendritic cells with diseased tissue cells, particularly tumor cells and media for such methods |
| 04/04/2002 | DE10045687A1 Expressionskassetten und Adenovirusvektoren Expression cassettes and adenovirus vectors |
| 04/04/2002 | DE10045591A1 Ortsspezifische, antikörpervermittelte Aktivierung proapoptotischer Zytokine - AMAIZe (Antibody-Mediated Apoptosis Inducing Zytokine) Site-specific, antibody-mediated activation of proapoptotic cytokines - Amaize (Antibody Mediated Apoptosis Inducing cytokines) |
| 04/04/2002 | DE10044856A1 Verfahren und Probenkit zur Analyse von nucleinsäurehaltigem Material Procedures and sample kit for analyzing nucleinsäurehaltigem material |
| 04/04/2002 | DE10044831A1 Verbessertes Verfahren zur mikrobiellen Herstellung von L-Serin sowie ein dazu geeigneter genetisch veränderter Mikroorganismus An improved method for the microbial production of L-serine as well as a thereto suitable genetically modified microorganism |
| 04/04/2002 | DE10041126A1 DNA-bindende Peptiddomänen und ein Verfahren zur Bereitstellung solcher Domänen DNA-binding peptide domains, and a method for providing such domains |
| 04/04/2002 | CA2760906A1 Sbmu200 gene and male tissue-prefered promotor, regulatory regions and methods of use in mediating plant male fertility |
| 04/04/2002 | CA2431571A1 Antisense iap nucleic acids and uses thereof |
| 04/04/2002 | CA2430987A1 Methods and compositions employing a novel stearoyl-coa desaturase-hscd5 |
| 04/04/2002 | CA2425208A1 Rna aptamers and methods for identifying the same |
| 04/04/2002 | CA2424004A1 Recombinant bcg vaccines for the prevention and treatment of cancer |
| 04/04/2002 | CA2423991A1 Pumpcn compositions and uses thereof |
| 04/04/2002 | CA2423955A1 Kini-3 motor protein and methods for its use |
| 04/04/2002 | CA2423954A1 A novel human g-protein coupled receptor, hgprbmy6, expressed highly in small intestine |
| 04/04/2002 | CA2423953A1 Hydrolases |
| 04/04/2002 | CA2423942A1 Human ion-exchanger proteins and polynucleotides encoding the same |
| 04/04/2002 | CA2423924A1 High density arrays |
| 04/04/2002 | CA2423922A1 Reagents, method and kit for detecting phosphinothricin-n-acetyltransferase protein |
| 04/04/2002 | CA2423870A1 Escherichia coli strains which over-produce l-threonine and processes for the production of l-threonine by fermentation |
| 04/04/2002 | CA2423863A1 Identification and cloning of a full-length human cink-related gene, mist (mast cell immunoreceptor signal transducer) |
| 04/04/2002 | CA2423720A1 Method for generating or increasing resistance to biotic or abiotic stress factors in organisms |
| 04/04/2002 | CA2423704A1 G-protein coupled receptors |
| 04/04/2002 | CA2423701A1 Oxidoreductases |
| 04/04/2002 | CA2423694A1 Transferases |
| 04/04/2002 | CA2423668A1 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 04/04/2002 | CA2423620A1 Nuclear reprogramming using iwsi and related chromatin remodeling atpases |
| 04/04/2002 | CA2423613A1 Transgenic drosophilia melanogaster expressing beta amyloid |
| 04/04/2002 | CA2423588A1 Improved vaccines for proliferative ileitis and methods of making and using the same |
| 04/04/2002 | CA2423492A1 A fibrin/fibrinogen-binding conjugate |
| 04/04/2002 | CA2423487A1 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 04/04/2002 | CA2423446A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/04/2002 | CA2423424A1 Secreted proteins |
| 04/04/2002 | CA2423413A1 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas |
| 04/04/2002 | CA2422891A1 Novel proteins and nucleic acids encoding same |
| 04/04/2002 | CA2422890A1 Method of predicting the clinical response to chemotherapeutic treatment with alkylating agents |
| 04/04/2002 | CA2422846A1 Lymphoma associated molecules and uses therefor |
| 04/04/2002 | CA2422530A1 Human drug metabolizing enzymes |
| 04/04/2002 | CA2422099A1 Identification of neuroblastoma tumor suppressor genes |
| 04/04/2002 | CA2421933A1 Assays for identifying receptors having alterations in signaling |
| 04/04/2002 | CA2421680A1 Antibodies for human cytochrome p450 2d6 |